B53 Other specified malaria

Name of the Condition

• Other specified malaria

Summary

Other specified malaria refers to malaria infections caused by Plasmodium species not classified under more specific ICD-10-CM categories. These infections may involve less common parasite strains or atypical presentations. The condition is characterized by fever, chills, and other systemic symptoms, with severity varying based on parasite type, host immunity, and treatment response.

Causes

The condition is caused by infection with Plasmodium parasites, transmitted through the bite of infected Anopheles mosquitoes. Less common species (e.g., P. knowlesi, P. malariae) or mixed infections may fall under this category when not specified elsewhere. Parasites invade red blood cells, leading to cyclical symptoms and potential complications.

Risk Factors

• Residence in or travel to malaria-endemic regions.
• Lack of prophylactic antimalarial medication during exposure.
• Immunocompromised states (e.g., HIV, chemotherapy) reducing resistance.
• Pregnancy, increasing severity and fetal risk.
• Previous malaria infection with incomplete immunity.

Symptoms

• Recurrent fever, chills, and sweats (classic paroxysmal cycles).
• Headache, muscle pain, and fatigue.
• Nausea, vomiting, or diarrhea.
• Jaundice or dark urine in severe cases.
• Anemia or splenomegaly with prolonged infection.

Diagnosis

Diagnosis involves clinical evaluation of symptoms and travel history, confirmed by laboratory tests. Microscopic examination of blood smears identifies parasite species and density. Rapid diagnostic tests (RDTs) detect parasite antigens, while PCR may identify species in complex cases. Differentiation from other febrile illnesses is critical.

Treatment Options

Treatment depends on parasite species, severity, and drug resistance patterns. First-line therapies include artemisinin-based combinations (ACTs) for P. falciparum or chloroquine for sensitive strains. Severe cases may require intravenous antimalarials, supportive care (e.g., fluids, transfusions), and management of complications like cerebral malaria.

Prognosis and Follow-Up

Prognosis varies by species and timeliness of treatment. Early intervention typically leads to full recovery, but delays or drug resistance can increase mortality. Follow-up includes monitoring for recurrence, anemia, or organ dysfunction. Chronic carriers may require surveillance in endemic areas.

Complications

• Severe anemia from hemolysis.
• Cerebral malaria with neurological impairment.
• Acute kidney injury or respiratory distress.
• Hypoglycemia or metabolic acidosis.
• Maternal or fetal complications in pregnancy.

Lifestyle & Prevention

• Use insect repellent and bed nets in endemic areas.
• Take prophylactic antimalarials as prescribed.
• Wear protective clothing to avoid mosquito bites.
• Drain standing water to reduce breeding sites.
• Seek prompt treatment for fever during/after travel.

When to Seek Professional Help

Consult a healthcare provider for unexplained fever after travel to malaria-endemic regions. Immediate care is needed for high fever, confusion, severe headache, or signs of organ failure (e.g., jaundice, difficulty breathing).

Tips for Medical Coders

Code B53 is assigned for malaria caused by unspecified or less common Plasmodium species not classified elsewhere. Documentation should specify the infecting species (if known) and clinical details (e.g., severity, treatment response) to support coding accuracy. Avoid using this code for unspecified malaria when a more specific code applies.